What is it about?
Charcot-Marie-Tooth disease type 1A (CMT1A) is a nerve condition where the body accidentally makes too much of a specific protein (PMP22). Strangely, having too much of this protein causes the protective insulation around our nerves to break down. This paper describes why this happens: the excess protein creates a major fat imbalance. It causes the body to lose the healthy, essential fats needed to build nerve insulation, while building up the wrong kind of storage fats instead. Without the right raw materials, the nerve coatings fall apart.
Featured Image
Photo by Pete Godfrey on Unsplash
Why is it important?
The exciting news is that because the problem is driven by missing fats, researchers think we might eventually treat CMT1A with targeted dietary supplements—like specific healthy fatty acids—to help rebuild that protective nerve coating.
Perspectives
This work fits with the recent works of others pinpointing to the disturbances in lipid metabolism as a driver of disease in demyelinating neuropathies. This is not only true for peripheral neuropathies but probably also of importance for demyelinating disease in the central nervous system
PhD Kees Fluiter
LUMC
Read the Original
This page is a summary of: Longitudinal analysis of lipid changes in the sciatic nerve caused by overexpression of PMP22 in murine models of CMT1A, Journal of Lipid Research, April 2026, Elsevier,
DOI: 10.1016/j.jlr.2026.101018.
You can read the full text:
Contributors
The following have contributed to this page
